How personality functioning shapes symptom development during and after treatment: A random intercept cross lagged panel analysis.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fuchshuber Jürgen, Kessler Henrik, Kehyayan Aram, Pape Magdalena, Hofmann Tobias, Rose Matthias, Imbierowicz Katrin, Geiser Franziska, Croy Ilona, Weidner Kerstin, Rademacher Jörg, Michalek Silke, Morawa Eva, Erim Yesim, Teufel Martin, Bäuerle Alexander, Heinzmann Stanislav, Lahmann Claas, Peters Eva Milena Johanne, Kruse Johannes, von Boetticher Dirk, Herrmann-Lingen Christoph, Nöhre Mariel, de Zwaan Martina, Dinger Ulrike, Friederich Hans-Christoph, Niecke Alexander, Albus Christian, Zwerenz Rüdiger, Beutel Manfred, Roenneberg Casper, Henningsen Peter, Stein Barbara, Waller Christiane, Hake Karsten, Spitzer Carsten, Stengel Andreas, Zipfel Stephan, Weimer Katja, Gündel Harald, Herpertz Stephan, Doering Stephan
Аннотация
METHODS: We reanalyzed observational data of 2094 participants (68% female; age M = 39.89 years; SD = 14.20 years) which took part in the Multicenter Effectiveness Study of Inpatient Psychosomatic Psychotherapeutic Treatment (short: MEPP) at three time points. A Random Intercept-Cross Lagged Panel Model (RI-CLPM) was used to examine within-person longitudinal effects between PF (OPD-SQS) and depressive symptoms (PHQ-9), anxiety (GAD-7) and somatic symptom load (PHQ-15). The model was controlled for age, sex, treatment condition and treatment length.
RESULTS: Strong between-person intercorrelations were observed between all investigated constructs. At the longitudinal within-person level PF at hospital discharge predicted somatic symptom load (p < .01), depressive symptoms, anxiety and itself (all p < .05) at follow up, however, PF showed no effect during treatment (p > .05). Furthermore, depressive symptoms at baseline influenced general symptom burden and PF development during treatment (all p < .05) and showed strong effects on anxiety and somatic symptoms at follow up (p < .001).
CONCLUSIONS: The results suggest a sustained influence of intraindividual PF deviations on general symptom development after psychotherapy, but also emphasize the effect of depressive symptoms in psychotherapy outcomes.